Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:actsOn |
positive allosteric modulator at GABAA receptor
|
| gptkbp:CASNumber |
60656-22-8
|
| gptkbp:class |
benzodiazepine derivative
|
| gptkbp:developedBy |
gptkb:Hoffmann-La_Roche
|
| gptkbp:drugClass |
benzodiazepine
sedative |
| gptkbp:hasMolecularFormula |
C18H15ClN2O3
|
| gptkbp:hasRelatedCompound |
gptkb:alpidem
gptkb:zolpidem L-838,417 SL-651,498 TPA-023 ZK-93423 |
| gptkbp:hasSMILES |
CCOC(=O)C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)C
|
| gptkbp:hasUNII |
6QK6V2WJ1D
|
| https://www.w3.org/2000/01/rdf-schema#label |
CL-218,872
|
| gptkbp:IUPACName |
ethyl 7-chloro-4-oxo-5-phenyl-2,3-dihydro-1,4-benzodiazepine-3-carboxylate
|
| gptkbp:legalStatus |
not approved for medical use
|
| gptkbp:PubChem_CID |
68728
|
| gptkbp:synonym |
ethyl 7-chloro-5-phenyl-2,3-dihydro-1,4-benzodiazepine-3-carboxylate
|
| gptkbp:bfsParent |
gptkb:YFL-577
|
| gptkbp:bfsLayer |
7
|